Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A recurrent case of left-sided endocarditis caused by high-level aminoglycoside-resistant Enterococcus faecalis was successfully treated with ceftaroline and daptomycin. This combination demonstrated excellent synergy in vitro . Mechanistically, ceftaroline enhanced binding of daptomycin to the cell membrane and sensitized E. faecalis to killing by human cathelicidin LL-37, a cationic innate host defense peptide. Daptomycin plus ceftaroline may be considered in salvage therapy in E. faecalis endovascular infections and requires further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of in vitro evaluations [214][215][216] suggested that ampicillin and ceftaroline in combination with daptomycin demonstrate the greatest synergistic activity compared with other β-lactam-daptomycin combinations.”
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Dvorchik, B. H., Brazier, D., DeBruin, M. F., & Arbeit, R. D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1318-1323.2003 · Cited by 358
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319 · cited 2×
“Microscopy method details have been described elsewhere (2, 8).”
MethodSelf-citationPharmacokinetics of ceftriaxone in humans
Patel, I. H., Chen, S., Parsonnet, M., Hackman, M. R., Brooks, M. A., Konikoff, J., & Kaplan, S. A. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.5.634 · Cited by 244
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00008 · Cited by 202 · cited 1×
“We point out that the ceftriaxone dose utilized initially was lower than that recommended in the literature and may have led to treatment failure (9).”
BackgroundSakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176 · cited 3×
“Microscopy method details have been described elsewhere (2, 8).”
BackgroundMethodSelf-citationPharmacokinetics of Sulbactam/Ampicillin in Humans: A Review
Foulds, G. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_5.503 · Cited by 137
Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci
Rand, K. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh104 · Cited by 112
Rose, W. E., Schulz, L. T., Andes, D., Striker, R., Berti, A. D., Hutson, P. R., & Shukla, S. K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00797-12 · Cited by 111 · cited 2×
“faecalis and Enterococcus faecium, and a published report of synergy between daptomycin and ceftaroline against MRSA (3), ampicillin was discontinued and ceftaroline at 600 mg i.”
Background
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
Ridyard, K. E., & Overhage, J. (2021) · Antibiotics · doi:10.3390/antibiotics10060650 · Cited by 270
“The combination has also been shown to sensitize Enterococcus faecalis to LL-37 [210].”
BackgroundA Current Perspective on Daptomycin for the Clinical Microbiologist
Humphries, R. M., Pollett, S., & Sakoulas, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-13 · Cited by 240
Self-citationBeganovic, M., Luther, M. K., Rice, L. B., Arias, C. A., Rybak, M. J., & LaPlante, K. L. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy064 · Cited by 234
“faecalis infections have been published [24, 26].”
BackgroundInfluentialMechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 234
Metadata
- Authors
- Sakoulas, G., Nonejuie, P., Nizet, V., Pogliano, J., Crum-Cianflone, N., & Haddad, F.
- Affiliations
- University of California San Diego (US)
- Division of Infectious Diseases, Naval Medical Center San Diego, San Diego, California, USA
- Sharp Grossmont Hospital (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-08
- Volume
- 57
- Issue
- 8
- Pages
- 4042-4045
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3719745
- OpenAlex
- W2030076485
- Semantic Scholar
- 83393aebf3bb4fa317d96fadf422d5cf2d77fa01
- Cited by
- 65
- References
- 9
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 3 · 2018: 6 · 2017: 7 · 2016: 6 · 2015: 12 · 2014: 8 · 2013: 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Forest Laboratories
- Pfizer Pharmaceuticals
- National Institute of Allergy and Infectious Diseases (U54AI057153, R01AI052453, R37AI052453)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD071600)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Enterococcus faecalis, infective endocarditis, daptomycin, ceftaroline, aminoglycoside resistance, gentamicin resistance, antibiotic synergy, cathelicidin LL-37, antimicrobial peptides, salvage therapy, endovascular infection, left-sided endocarditis
- MeSH terms
- Ceftaroline, Anti-Bacterial Agents, Cell Membrane, Cephalosporins, Drug Synergism, Endocarditis, Bacterial, Gentamicins, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Enterococcus faecalis, Daptomycin, Antimicrobial Cationic Peptides, Drug Resistance, Bacterial, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline. https://app.cochat.ai/papers/10.1128/aac.02481-12
- The paper
- Sakoulas, G., Nonejuie, P., Nizet, V., Pogliano, J., Crum-Cianflone, N., & Haddad, F. (2013). Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.02481-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.